Announced
Completed
Syncona led a £20m series A funding round in Kesmalea.
Synopsis
Syncona, a British closed-ended investment trust, led a £20m series A funding round in Kesmalea, a small molecule drug discovery company.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Bidder Team (5)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite